Amneal Pharmaceuticals, Inc is a drug manufacturers-specialty & generic business based in the US. Amneal Pharmaceuticals shares (AMRX) are listed on the NYSE and all prices are listed in US Dollars. Amneal Pharmaceuticals employs 6,000 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Amneal Pharmaceuticals
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AMRX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Amneal Pharmaceuticals stock price (NYSE: AMRX)Use our graph to track the performance of AMRX stocks over time.
Amneal Pharmaceuticals shares at a glance
|Latest market close||$5.66|
|52-week range||$3.45 - $7.45|
|50-day moving average||$5.11|
|200-day moving average||$5.53|
|Wall St. target price||$6.69|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.61|
Buy Amneal Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Amneal Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Amneal Pharmaceuticals price performance over time
|1 week (2021-07-21)||N/A|
|1 month (2021-07-01)||7.20%|
|3 months (2021-04-30)||2.72%|
|6 months (2021-01-28)||N/A|
|1 year (2020-07-28)||N/A|
|2 years (2019-07-28)||N/A|
|3 years (2018-07-28)||N/A|
|5 years (2016-07-28)||N/A|
Is Amneal Pharmaceuticals under- or over-valued?
Valuing Amneal Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Amneal Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Amneal Pharmaceuticals's EBITDA
Amneal Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $358.3 million.
The EBITDA is a measure of a Amneal Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.
Amneal Pharmaceuticals financials
|Revenue TTM||$2 billion|
|Operating margin TTM||6.31%|
|Gross profit TTM||$652.3 million|
|Return on assets TTM||1.88%|
|Return on equity TTM||-9.65%|
|Market capitalisation||$736.2 million|
TTM: trailing 12 months
Shorting Amneal Pharmaceuticals shares
There are currently 4.8 million Amneal Pharmaceuticals shares held short by investors – that's known as Amneal Pharmaceuticals's "short interest". This figure is 6.5% up from 4.5 million last month.
There are a few different ways that this level of interest in shorting Amneal Pharmaceuticals shares can be evaluated.
Amneal Pharmaceuticals's "short interest ratio" (SIR)
Amneal Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Amneal Pharmaceuticals shares currently shorted divided by the average quantity of Amneal Pharmaceuticals shares traded daily (recently around 855660.42780749). Amneal Pharmaceuticals's SIR currently stands at 5.61. In other words for every 100,000 Amneal Pharmaceuticals shares traded daily on the market, roughly 5610 shares are currently held short.
However Amneal Pharmaceuticals's short interest can also be evaluated against the total number of Amneal Pharmaceuticals shares, or, against the total number of tradable Amneal Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Amneal Pharmaceuticals's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Amneal Pharmaceuticals shares in existence, roughly 30 shares are currently held short) or 0.0504% of the tradable shares (for every 100,000 tradable Amneal Pharmaceuticals shares, roughly 50 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Amneal Pharmaceuticals.
Find out more about how you can short Amneal Pharmaceuticals stock.
Amneal Pharmaceuticals share dividends
We're not expecting Amneal Pharmaceuticals to pay a dividend over the next 12 months.
Amneal Pharmaceuticals share price volatility
Over the last 12 months, Amneal Pharmaceuticals's shares have ranged in value from as little as $3.45 up to $7.445. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Amneal Pharmaceuticals's is 1.2647. This would suggest that Amneal Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Amneal Pharmaceuticals overview
Amneal Pharmaceuticals, Inc. , together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates in three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, promotion, distribution, and sale of branded pharmaceutical products primarily for central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas. It also offers licensed, owned, niche, and mature branded products, as well as Rytary for the treatment of Parkinson's disease; Zomig for the treatment of migraine headaches; Emverm a chewable tablets for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or mixed infections; and Unithroid for the treatment of hypothyroidism. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs.
Stocks similar to Amneal Pharmaceuticals
Amneal Pharmaceuticals in the news
10 Best Medical Stocks Under $10
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
Amneal Receives Approval for Generic TobraDex®
Frequently asked questionsWhat percentage of Amneal Pharmaceuticals is owned by insiders or institutions?
Currently 10.551% of Amneal Pharmaceuticals shares are held by insiders and 70.302% by institutions. How many people work for Amneal Pharmaceuticals?
Latest data suggests 6,000 work at Amneal Pharmaceuticals. When does the fiscal year end for Amneal Pharmaceuticals?
Amneal Pharmaceuticals's fiscal year ends in December. Where is Amneal Pharmaceuticals based?
Amneal Pharmaceuticals's address is: 400 Crossing Boulevard, Bridgewater, NJ, United States, 08807 What is Amneal Pharmaceuticals's ISIN number?
Amneal Pharmaceuticals's international securities identification number is: US03168L1052 What is Amneal Pharmaceuticals's CUSIP number?
Amneal Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 03168L105
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert